The Risk and Outcomes of Reoperative Tricuspid Valve Surgery

Slides:

Advertisements

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Advertisements

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,

What Predicts Long-Term Survival After Heart Transplantation

The STS National Database

Neonatal Flail Tricuspid Valve: Diagnosis and Management

Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population Christina M. Vassileva,

Adam N. Protos, MD, Jaimin R. Trivedi, MD, MPH, William M

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Outcomes of Reintervention on the Autograft After Ross Procedure

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Giovanni Mariscalco, MD, PhD, Francesco Musumeci, MD

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Tetralogy of Fallot: surgical management individualized to the patient

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani Daneshmand, MD, J

Jonathan W. Cramer, MD, Salil Ginde, MD, Garick D. Hill, MD, Scott B

Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis

Operative Results and Outcomes in Children With Shone's Anomaly

Does Prior Coronary Bypass Surgery Present a Unique Risk for Reoperative Valve Surgery? Andrew Breglio, BS, Anelechi Anyanwu, MD, Shinobu Itagaki, MD,

Outcomes of Early Mitral Valve Reoperation in the Medicare Population

Tetralogy of Fallot: Results of a Pulmonary Valve-Sparing Strategy

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Origins of the Cardiothoracic Surgery Network (CTSNet)

Who Do You Say You Are? The Annals of Thoracic Surgery

Robert J. Moraca, MD, Marc R. Moon, MD, Jennifer S

The “Double-Valve” Sign in Acute Type A Aortic Dissection

Andreas Zierer, MD, Rochus K. Voeller, MD, Karen E

Use of Amiodarone After Major Lung Resection

Long-term results of mitral valve repair for myxomatous disease with and without chordal replacement with expanded polytetrafluoroethylene sutures Tirone.

Maria Kalliopi Konstantinidou, MD, PhD, Neil Moat, MD, PhD

Zain Khalpey, MD, PhD, Wernard Borstlap, Patrick O. Myers, MD, Jan D

Appraisal of Long-Term Outcomes of Tricuspid Valve Replacement in the Current Perspective Amedeo Anselmi, MD, PhD, Vito Giovanni Ruggieri, MD, PhD, Majid.

Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Redo Aortic Valve Replacement in Children

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Editorial Board, January 2010

Long-Term Survival and Freedom From Reoperation After Placement of a Pulmonary Xenograft Valved Conduit George M. Alfieris, MD, Michael F. Swartz, PhD,

Midterm Outcome of Valve-Sparing Aortic Root Replacement in Inherited Connective Tissue Disorders Hiroshi Tanaka, MD, PhD, Hitoshi Ogino, MD, PhD, Hitoshi.

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Ralph W. White, FRCS (CTh), Jeremy Rushbrook, MRCS, Mohan U

Deterioration of a Tricuspid Bioprosthesis Due to Adhesion of the Native Valve Herbert Gutermann, MD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD

Tirone E. David, MD, Carolyn M. David, BN, Cedric Manlhiot, MS

Transcatheter Aortic Valve Replacement Versus Aortic Valve Bypass

Outcome of Patients With Aortic Stenosis Referred to a Multidisciplinary Meeting for Transcatheter Valve Marjan Jahangiri, FRCS, Jean Claude Laborde,

Specialty Training and Mortality After Esophageal Cancer Resection

Paul Urbanski, MD, PhD The Annals of Thoracic Surgery

Cost-Effectiveness of Mitral Valve Repair Versus Replacement by Biologic or Mechanical Prosthesis Ariel Beresniak, MD, PhD, Brigitte Sabatier, PharmD,

Twenty-Five Year Outcomes of Tricuspid Valve Replacement Comparing Mechanical and Biologic Prostheses Andrea Garatti, MD, Giovanni Nano, MD, Giuseppe.

Invited Commentary The Annals of Thoracic Surgery

Tricuspid Valve Repair of Idiopathic Papillary Muscle Rupture

“Prophylactic” Tricuspid Repair for Functional Tricuspid Regurgitation

Stefano Zoli, MD, Christian D

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Patient-Prosthesis Mismatch After Mitral Valve Replacement: A Propensity Score Analysis Ho Young Hwang, MD, PhD, Yong Han Kim, MD, Kyung-Hwan Kim, MD,

Early and Midterm Outcomes for Tricuspid Valve Surgery After Left-Sided Valve Surgery Choung Kyu Park, MD, Pyo Won Park, MD, Kiick Sung, MD, Young Tak.

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

John M. Stulak, MD, Harold M. Burkhart, MD, Joseph A

The Impact of New Technology on Cardiothoracic Surgical Practice

Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement Heinrich Koertke, MD,

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Umar S. Boston, MD, Joseph A. Dearani, MD, Patrick W

Risk of Valve-Related Events After Aortic Valve Repair

Heart Transplant Program Volume Is Not a Measure of Quality

Thanos Sioris, MD, Tirone E

Michael O. Kayatta, MD, Bradley G

Repair of Left Ventricular Inflow Tract Lesions in Shone's Anomaly: Valve Growth and Long-Term Outcome Eva Maria B. Delmo Walter, MD, PhD, Richard Van.

Presentation transcript:

The Risk and Outcomes of Reoperative Tricuspid Valve Surgery Reubendra Jeganathan, FRCSI (CTh), Susan Armstrong, MS, Bassel Al-Alao, MRCS, Tirone David, MD The Annals of Thoracic Surgery Volume 95, Issue 1, Pages 119-124 (January 2013) DOI: 10.1016/j.athoracsur.2012.08.058 Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Survival according to tricuspid valve pathology. (Black line = functional, n = 50; gray line = organic, n = 18.) The Annals of Thoracic Surgery 2013 95, 119-124DOI: (10.1016/j.athoracsur.2012.08.058) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Survival according to tricuspid valve surgery. (Black line = repair, n = 42; gray line = replacement, n = 26.) The Annals of Thoracic Surgery 2013 95, 119-124DOI: (10.1016/j.athoracsur.2012.08.058) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Survival after redo tricuspid valve surgery. (A) Entire cohort of patients (n = 68); (B) hospital survivors (n = 59). The Annals of Thoracic Surgery 2013 95, 119-124DOI: (10.1016/j.athoracsur.2012.08.058) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions